HOME >> MEDICINE >> NEWS
Subanalysis finds patient-controlled, transdermal pain management system may be comparable

Phoenix, Arizona, November 15, 2004 - Researchers have reported that IONSYSTM, a novel patient-controlled, transdermal, analgesic system that delivers fentanyl through the skin, may be comparable to intravenous patient-controlled analgesia (IV PCA) when used after gynecologic surgery. This needle-free system for managing acute pain in the hospital setting is currently under review by the Food and Drug Administration (FDA), and was granted approvable status in June, 2004. These data were presented at the American Society of Regional Anesthesia & Pain Medicine Annual Fall Pain Meeting.

This research is a subanalysis of a broader, head-to-head study published earlier this year in the Journal of the American Medical Association (JAMA). The complete set of data showed that 316 adult patients receiving IONSYSTM following major surgery experienced similar pain relief as that experienced with IV PCA morphine. This subanalysis focuses on the women in the study who had undergone gynecologic surgery. Patients received either IONSYSTM fentanyl HCl 40mcg -- a system that is designed to be the first and only needle-free, patient-controlled, transdermal analgesic to treat acute pain -- or the current standard of therapy, morphine via IV PCA. IONSYSTM currently is under development and not yet commercially available.

Researchers reported no statistically-significant differences between the two methods in patients' overall pain control, the amount of supplemental pain medication required, or the number of patients withdrawing from the study due to inadequate pain relief. Side effects were similar in both groups.

"In 2002, there were more than a million gynecologic surgeries performed in the United States," said Shireen Ahmad, M.D., Assistant Professor, Department of Anesthesiology at Northwestern University. "In this subanalysis, IONSYSTM provided post-operative pain relief to most patients und
'"/>


15-Nov-2004


Page: 1 2 3

Related medicine news :

1. Study finds that coordinating care of chronically ill patients does not increase liability
2. Bullying among sixth graders a daily occurrence, UCLA study finds
3. Study finds factors linked to substance use disorder relapse among health care professionals
4. Study finds majority of women willing to accept cervical cancer vaccine for self and children
5. Boston University team finds link between high cholesterol and better cognitive performance
6. Risk of cardiac death after radiotherapy for breast cancer has declined, study finds
7. Study finds direct association between cardiovascular disease and periodontal bacteria
8. Emory Study finds HIV is not an independent risk factor for severe heart disease
9. Study finds indoor allergen levels vary, cockroach allergens cause more asthma symptoms
10. Study finds drug eluting stents as effective as vascular brachytherapy in preventing restenosis
11. Men more likely to get screened for prostate cancer than colon cancer, U-M study finds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... 22, 2017 , ... PITTSBURGH...Defibrillators are used to treat a ... one isn’t accessible in certain locations, the risk of death can be very ... this idea," said an inventor from Ridgecrest, Calif. , The MOBILE AUTOMATED EXTERNAL ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student from Sonora, California, ... Leadership and Administration at St. Thomas University in Miami, Florida, was selected from ...
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice Emergency ... the one year anniversary of its Houston-Fallbrook facility. , “We are honored ... Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a pleasure ...
(Date:9/22/2017)... Diego, CA (PRWEB) , ... September 22, 2017 ... ... offer groceries, wearable, and more products at customers’ doorstep. According to Smart Mart, ... Smart Mart has stated to offer wearable, and customers can find clothing at ...
(Date:9/21/2017)... Falls Church, VA (PRWEB) , ... September 21, ... ... **An FDAnews Webinar**, Sept. 26, 2017 — 1:30 p.m. – 3:00 p.m. ET, ... exacting business. It’s easy to get things wrong, run afoul of The Quality ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)...   OrthoAtlanta has been named the official orthopedic ... (AFHC) for the 2018 College Football Playoff (CFP) National Championship ... Stadium in Atlanta, Georgia . OrthoAtlanta is ... campaign, participating in many activities leading up to, and including ... ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
(Date:9/9/2017)... , Sept. 9, 2017  Eli Lilly and Company ... and secondary endpoint data for lasmiditan, an investigational, oral, ... demonstrated statistically significant improvements compared to placebo in the ... today at the 18th Congress of the International Headache ... "The data presented today demonstrate lasmiditan,s potential to ...
Breaking Medicine Technology:
Cached News: